These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 16968948)

  • 1. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
    Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.
    Norel X; Brink C
    Pharmacol Ther; 2004 Jul; 103(1):81-94. PubMed ID: 15251228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
    Brink C; Dahlén SE; Drazen J; Evans JF; Hay DW; Nicosia S; Serhan CN; Shimizu T; Yokomizo T
    Pharmacol Rev; 2003 Mar; 55(1):195-227. PubMed ID: 12615958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosanoids in asthma.
    Wan KS; Wu WF
    Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
    El Kebir D; József L; Filep JG
    J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin receptors.
    Romano M; Recchia I; Recchiuti A
    ScientificWorldJournal; 2007 Sep; 7():1393-412. PubMed ID: 17767357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.
    Simiele F; Recchiuti A; Mattoscio D; De Luca A; Cianci E; Franchi S; Gatta V; Parolari A; Werba JP; Camera M; Favaloro B; Romano M
    FASEB J; 2012 Mar; 26(3):1323-33. PubMed ID: 22131270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxin A4 is a novel estrogen receptor modulator.
    Russell R; Gori I; Pellegrini C; Kumar R; Achtari C; Canny GO
    FASEB J; 2011 Dec; 25(12):4326-37. PubMed ID: 21885654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
    Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
    FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
    Fu H; Björkman L; Janmey P; Karlsson A; Karlsson J; Movitz C; Dahlgren C
    BMC Cell Biol; 2004 Dec; 5(1):50. PubMed ID: 15625007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
    Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
    Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
    J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.